FDA Draft Guidance Stretches Nanotech “Perhaps Massively” – Trade Group
This article was originally published in The Tan Sheet
Executive Summary
FDA's draft guidance suggesting ingredients up to 1 micrometer in size that exhibit “altered properties” still qualify as nanomaterials should be revised to avoid confusion in the marketplace and promote international harmonization, according to the Personal Care Products Council.
You may also be interested in...
CHPA Urges Nuanced, Risk-Based Approach To Nanotechnology
FDA should not use size alone to regulate nanotechnology, the Consumer Healthcare Products Association says.
FDA Nanotech Guidance Takes Small Step Forward
FDA initiates a dialogue with industry on nanotechnology in regulated products via a broad draft guidance document.
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.